Minireview: Implication of mitochondria in insulin secretion and action

Endocrinology

Volumn 147, Issue 6, 2006, Pages 2643-2649

  Wiederkehr, Andreas ^a   Wollheim, Claes B ^a,b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b University Medical Center   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; DNA POLYMERASE; FATTY ACID; GLUCOSE; INSULIN; TRANSCRIPTION FACTOR; UNCOUPLING PROTEIN 2;

AEROBIC METABOLISM; CALCIUM TRANSPORT; CELL MEMBRANE; CYTOSOL; DIABETES MELLITUS; DISEASE MODEL; ENERGY YIELD; GLUCOSE OXIDATION; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SHORT SURVEY;

ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM; DIABETES MELLITUS, TYPE 2; EXOCYTOSIS; GLUCOSE; HUMANS; INSULIN; ION CHANNELS; MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS;

EID: 33646779855     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0057     Document Type: Short Survey

References (72)

1. Maechler P 2002 Mitochondria as the conductor of metabolic signals for insulin exocytosis in pancreatic β-cells. Cell Mol Life Sci 59:1803-1818
2. Duchen MR 2004 Mitochondria in health and disease: perspectives on a new mitochondrial biology. Mol Aspects Med 25:365-451
3. Lowell BB, Shulman GI 2005 Mitochondrial dysfunction and type 2 diabetes. Science 307:384-387
4. Wollheim CB, Maechler P 2002 β-Cell mitochondria and insulin secretion: messenger role of nucleotides and metabolites. Diabetes 51(Suppl 1):S37-S42
5. Henquin JC 2004 Pathways in β-cell stimulus-secretion coupling as targets for therapeutic insulin secretagogues. Diabetes 53(Suppl 3):S48-S58
6. Maechler P, Carobbio S, Rubi B 2006 In β-cells, mitochondria integrate and generate metabolic signals controlling insulin secretion. Int J Biochem Cell Biol 38(5-6):696-709
7. Matschinsky FM 2002 Regulation of pancreatic β-cell glucokinase: from basics to therapeutics. Diabetes 51(Suppl 3):S394-S404
8. Sekine N, Cirulli V, Regazzi R, Brown LJ, Gine E, Tamarit-Rodriguez J, Girotti M, Marie S, MacDonald MJ, Wollheim CB 1994 Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic β-cells. Potential role in nutrient sensing. J Biol Chem 269:4895-4902
9. Schuit F, De Vos A, Farfari S, Moens K, Pipeleers D, Brun T, Prentki M 1997 Metabolic fate of glucose in purified islet cells. Glucose-regulated anaplerosis in β cells. J Biol Chem 272:18572-18579
10. 13C NMR isotopomer analysis of anaplerotic pathways in INS-1 cells. J Biol Chem 279:44370-44375
11. 13C NMR isotopomer analysis reveals a connection between pyruvate cycling and glucose-stimulated insulin secretion (GSIS). Proc Natl Acad Sci USA 99:2708-2713
12. Arco AD, Satrustegui J 2005 New mitochondrial carriers: an overview. Cell Mol Life Sci 62:2204-2227
13. Rubi B, del Arco A, Bartley C, Satrustegui J, Maechler P 2004 The malate-aspartate NADH shuttle member aralar1 determines glucose metabolic fate, mitochondrial activity, and insulin secretion in β cells. J Biol Chem 279:55659-55666
14. Noda M, Yamashita S, Takahashi N, Eto K, Shen LM, Izumi K, Daniel S, Tsubamoto Y, Nemoto T, Iino M, Kasai H, Sharp GW, Kadowaki T 2002 Switch to anaerobic glucose metabolism with NADH accumulation in the β-cell model of mitochondrial diabetes. Characteristics of βHC9 cells deficient in mitochondrial DNA transcription. J Biol Chem 277:41817-41826
15. Eto K, Tsubamoto Y, Terauchi Y, Sugiyama T, Kishimoto T, Takahashi N, Yamauchi N, Kubota N, Murayama S, Aizawa T, Akanuma Y, Aizawa S, Kasai H, Yazaki Y, Kadowaki T 1999 Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion. Science 283:981-985
16. Kennedy ED, Maechler P, Wollheim CB 1998 Effects of depletion of mitochondrial DNA in metabolism secretion coupling in INS-1 cells. Diabetes 47:374-380
17. Ishihara H, Maechler P, Gjinovci A, Herrera PL, Wollheim CB 2003 Islet β-cell secretion determines glucagon release from neighbouring α-cells. Nat Cell Biol 5:330-335
18. Antinozzi PA, Ishihara H, Newgard CB, Wollheim CB 2002 Mitochondrial metabolism sets the maximal limit of fuel-stimulated insulin secretion in a model pancreatic β cell: a survey of four fuel secretagogues. J Biol Chem 277:11746-11755
19. + channels. Diabetes 51:875-879
20. Rorsman P, Renstrom E 2003 Insulin granule dynamics in pancreatic β cells. Diabetologia 46:1029-1045
21. 2+ transients. J Biol Chem 269:27310-27314
22. 1-ATPase. Am J Physiol 278:C423-C435
23. Wollheim CB 2000 β-Cell mitochondria in the regulation of insulin secretion: a new culprit in type II diabetes. Diabetologia 43:265-277
24. + signals to neuronal mitochondria. J Biol Chem 281:1039-1047
25. 2+ exchanger increases mitochondrial metabolism and potentiates glucose-stimulated insulin secretion in rat pancreatic islets. Diabetes 52:965-973
26. 2+ handling in human complex I deficiency. J Biol Chem 279:40328-40336
27. Gembal M, Gilon P, Henquin JC 1992 Evidence that glucose can control insulin release independently from its action on ATP-sensitive K+ channels in mouse B cells. J Clin Invest 89:1288-1295
28. Maechler P, Kennedy ED, Pozzan T, Wollheim CB 1997 Mitochondrial activation directly triggers the exocytosis of insulin in permeabilized pancreatic β-cells. EMBO J 16:3833-3841
29. Maechler P, Wollheim CB 1999 Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis. Nature 402:685-689
30. Farfari S, Schulz V, Corkey B, Prentki M 2000 Glucose-regulated anaplerosis and cataplerosis in pancreatic β-cells: possible implication of a pyruvate/ citrate shuttle in insulin secretion. Diabetes 49:718-726
31. Deeney JT, Prentki M, Corkey BE 2000 Metabolic control of β-cell function. Semin Cell Dev Biol 11:267-275
32. Deeney JT, Gromada J, Hoy M, Olsen HL, Rhodes CJ, Prentki M, Berggren PO, Corkey BE 2000 Acute stimulation with long chain acyl-CoA enhances exocytosis in insulin-secreting cells (HIT T-15 and NMRI β-cells). J Biol Chem 275:9363-9368
33. Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, Bajaj M, Mandarino L, DeFronzo R, Cusi K 2003 A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52:2461-2474
34. Boucher A, Lu D, Burgess SC, Telemaque-Potts S, Jensen MV, Mulder H, Wang MY, Unger RH, Sherry AD, Newgard CB 2004 Biochemical mechanism of lipid-induced impairment of glucose-stimulated insulin secretion and reversal with a malate analogue. J Biol Chem 279:27263-27271
35. Ivarsson R, Quintens R, Dejonghe S, Tsukamoto K, in 't Veld P, Renstrom E, Schuit FC 2005 Redox control of exocytosis: regulatory role of NADPH, thioredoxin, and glutaredoxin. Diabetes 54:2132-2142
36. Bertrand G, Ishiyama N, Nenquin M, Ravier MA, Henquin JC 2002 The elevation of glutamate content and the amplification of insulin secretion in glucose-stimulated pancreatic islets are not causally related. J Biol Chem 277:32883-32891
37. Broca C, Brennan L, Petit P, Newsholme P, Maechler P 2003 Mitochondria-derived glutamate at the interplay between branched-chain amino acid and glucose-induced insulin secretion. FEBS Lett 545:167-172
38. Hoy M, Maechler P, Efanov AM, Wollheim CB, Berggren PO, Gromada J 2002 Increase in cellular glutamate levels stimulates exocytosis in pancreatic β-cells. FEBS Lett 531:199-203
39. Kelly A, Li C, Gao Z, Stanley CA, Matschinsky FM 2002 Glutaminolysis and insulin secretion: from bedside to bench and back. Diabetes 51(Suppl 3):S421-S426
40. Maechler P, Wollheim CB 2001 Mitochondrial function in normal and diabetic β-cells. Nature 414:807-812
41. Maassen JA, Janssen GM, t Hart LM 2005 Molecular mechanisms of mitochondrial diabetes (MIDD). Ann Med 37:213-221
42. Kobayashi T, Nakanishi K, Nakase H, Kajio H, Okubo M, Murase T, Kosaka K 1997 In situ characterization of islets in diabetes with a mitochondrial DNA mutation at nucleotide position 3243. Diabetes 46:1567-1571
43. Weir GC, Bonner-Weir S 2004 Five stages of evolving β-cell dysfunction during progression to diabetes. Diabetes 53(Suppl 3):S16-S21
44. Balaban RS, Nemoto S, Finkel T 2005 Mitochondria, oxidants, and aging. Cell 120:483-495
45. Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, Bohlooly YM, Gidlof S, Oldfors A, Wibom R, Tornell J, Jacobs HT, Larsson NG 2004 Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429:417-423
46. Michikawa Y, Mazzucchelli F, Bresolin N, Scarlato G, Attardi G 1999 Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science 286:774-779
47. Ristow M, Mulder H, Pomplun D, Schulz TJ, Muller-Schmehl K, Krause A, Fex M, Puccio H, Muller J, Isken F, Spranger J, Muller-Wieland D, Magnuson MA, Mohlig M, Koenig M, Pfeiffer AF 2003 Frataxin deficiency in pancreatic islets causes diabetes due to loss of β cell mass. J Clin Invest 112:527-534
48. Bindokas VP, Kuznetsov A, Sreenan S, Polonsky KS, Roe MW, Philipson LH 2003 Visualizing superoxide production in normal and diabetic rat islets of Langerhans. J Biol Chem 278:9796-9801
49. Krauss S, Zhang CY, Scorrano L, Dalgaard LT, St-Pierre J, Grey ST, Lowell BB 2003 Superoxide-mediated activation of uncoupling protein 2 causes pancreatic β cell dysfunction. J Clin Invest 112:1831-1842
50. Martens GA, Cai Y, Hinke S, Stange G, Van de Casteele M, Pipeleers D 2005 Glucose suppresses superoxide generation in metabolically responsive pancreatic β cells. J Biol Chem 280:20389-20396
51. Tiedge M, Lortz S, Drinkgern J, Lenzen S 1997 Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 46:1733-1742
52. Hsu CC, Yen HF, Yin MC, Tsai CM, Hsieh CH 2004 Five cysteine-containing compounds delay diabetic deterioration in BALB/cA mice. J Nutr 134:3245-3249
53. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC 2003 β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110
54. Donath MY, Ehses JA, Maedler K, Schumann DM, Ellingsgaard H, Eppler E, Reinecke M 2005 Mechanisms of β-cell death in type 2 diabetes. Diabetes 54(Suppl 2):S108-S113
55. Sesti G, Cardellini M, Marini MA, Frontoni S, D'Adamo M, Del Guerra S, Lauro D, De Nicolais P, Sbraccia P, Del Prato S, Gambardella S, Federici M, Marchetti P, Lauro R 2003 A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. Diabetes 52:1280-1283
56. Zhang CY, Baffy G, Perret P, Krauss S, Peroni O, Grujic D, Hagen T, Vidal-Puig AJ, Boss O, Kim YB, Zheng XX, Wheeler MB, Shulman GI, Chan CB, Lowell BB 2001 Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, β cell dysfunction, and type 2 diabetes. Cell 105:745-755
57. Zengaffinen N, Perreten H, Lameloise N, Keller P, Muzzin P, Assimacopoulos-Jeannet F 2005 Uncoupling protein 2 overexpression prevents cytokine-induced reactive oxygen species production and apoptosis in pancreatic β cells. Diabetologia 48:A38
58. Ekstrand MI, Falkenberg M, Rantanen A, Park CB, Gaspari M, Hultenby K, Rustin P, Gustafsson CM, Larsson NG 2004 Mitochondrial transcription factor A regulates mtDNA copy number in mammals. Hum Mol Genet 13:935-944
59. Silva JP, Kohler M, Graff C, Oldfors A, Magnuson MA, Berggren PO, Larsson NG 2000 Impaired insulin secretion and β-cell loss in tissue-specific knockout mice with mitochondrial diabetes. Nat Genet 26:336-340
60. Gauthier BR, Brun T, Sarret EJ, Ishihara H, Schaad O, Descombes P, Wollheim CB 2004 Oligonucleotide microarray analysis reveals PDX1 as an essential regulator of mitochondrial metabolism in rat islets. J Biol Chem 279:31121-31130
61. +/- mice. J Clin Invest 111:1147-1160
62. Biddinger SB, Kahn CR 2005 From mice to men: insights into the insulin resistance syndromes. Annu Rev Physiol 68:123-158
63. Schrauwen P, Hesselink MK 2004 Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 53:1412-1417
64. Storgaard H, Jensen CB, Bjornholm M, Song XM, Madsbad S, Zierath JR, Vaag AA 2004 Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes. J Clin Endocrinol Metab 89:1301-1311
65. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI 2003 Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300:1140-1142
66. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI 2004 Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664-671
67. Stump CS, Short KR, Bigelow ML, Schimke JM, Nair KS 2003 Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc Natl Acad Sci USA 100:7996-8001
68. Ruderman N, Prentki M 2004 AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nat Rev Drug Discov 3:340-351
69. Leclerc I, Woltersdorf WW, da Silva Xavier G, Rowe RL, Cross SE, Korbutt GS, Rajotte RV, Smith R, Rutter GA 2004 Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion. Am J Physiol 286:E1023-E1031
70. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC 2003 PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267-273
71. Yoon JC, Xu G, Deeney JT, Yang SN, Rhee J, Puigserver P, Levens AR, Yang R, Zhang CY, Lowell BB, Berggren PO, Newgard CB, Bonner-Weir S, Weir G, Spiegelman BM 2003 Suppression of β cell energy metabolism and insulin release by PGC-1α. Dev Cell 5:73-83
72. Hu Z, Dai Y, Prentki M, Chohnan S, Lane MD 2005 A role for hypothalamic malonyl-CoA in the control of food intake. J Biol Chem 280:39681-39683